Biophytis Correlations
| BPTS Stock | USD 8.02 1.40 14.86% |
The correlation of Biophytis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biophytis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biophytis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Biophytis and NYA is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biophytis and NYA in the same portfolio, assuming nothing else is changed.
Biophytis |
The ability to find closely correlated positions to Biophytis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biophytis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biophytis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biophytis to buy it.
Moving together with Biophytis Stock
| 0.84 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.62 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.87 | BKRKY | Bank Rakyat | PairCorr |
| 0.67 | PTBRY | Bank Negara Indonesia | PairCorr |
| 0.8 | BA | Boeing Sell-off Trend | PairCorr |
| 0.81 | MCD | McDonalds Financial Report 25th of July 2024 | PairCorr |
| 0.7 | IBM | International Business Financial Report 17th of July 2024 | PairCorr |
Moving against Biophytis Stock
| 0.92 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.9 | AA | Alcoa Corp Buyout Trend | PairCorr |
| 0.82 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
| 0.81 | XOM | Exxon Mobil Corp Financial Report 26th of July 2024 | PairCorr |
| 0.6 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.52 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.49 | PG | Procter Gamble Financial Report 26th of July 2024 | PairCorr |
| 0.45 | NVDA | NVIDIA Financial Report 22nd of May 2024 | PairCorr |
Related Correlations Analysis
| -0.32 | 0.68 | -0.8 | 0.8 | CVRX | ||
| -0.32 | -0.59 | 0.18 | -0.3 | BTCY | ||
| 0.68 | -0.59 | -0.51 | 0.56 | BBLG | ||
| -0.8 | 0.18 | -0.51 | -0.77 | DCTH | ||
| 0.8 | -0.3 | 0.56 | -0.77 | HSCS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biophytis Stock performing well and Biophytis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biophytis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CVRX | 3.63 | (1.66) | 0.00 | (0.86) | 0.00 | 5.50 | 40.66 | |||
| BTCY | 6.04 | 0.92 | 0.12 | (0.61) | 5.49 | 16.54 | 48.34 | |||
| BBLG | 4.86 | (0.61) | 0.00 | (0.24) | 0.00 | 8.70 | 58.44 | |||
| DCTH | 2.60 | 0.16 | 0.08 | 0.15 | 2.68 | 6.72 | 16.70 | |||
| HSCS | 4.21 | (0.63) | 0.00 | 6.81 | 0.00 | 10.00 | 66.24 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biophytis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Biophytis Corporate Management
Elected by the shareholders, the Biophytis' board of directors comprises two types of representatives: Biophytis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biophytis. The board's role is to monitor Biophytis' management team and ensure that shareholders' interests are well served. Biophytis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biophytis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edouard Bieth | Chief Officer | Profile | |
| Philippe Rousseau | Chief Officer | Profile | |
| Waly Dioh | Chief Officer | Profile | |
| Pierre Dilda | Chief Officer | Profile | |
| Benoit Canolle | Chief Officer | Profile | |
| Stanislas Veillet | Chairman CEO | Profile | |
| Rene Lafont | Scientific Board | Profile |
Already Invested in Biophytis?
The danger of trading Biophytis is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biophytis is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biophytis. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biophytis is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biophytis is a strong investment it is important to analyze Biophytis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biophytis' future performance. For an informed investment choice regarding Biophytis Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biophytis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Biophytis Stock please use our How to Invest in Biophytis guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Biophytis Stock analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Biophytis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biophytis. If investors know Biophytis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biophytis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biophytis is measured differently than its book value, which is the value of Biophytis that is recorded on the company's balance sheet. Investors also form their own opinion of Biophytis' value that differs from its market value or its book value, called intrinsic value, which is Biophytis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biophytis' market value can be influenced by many factors that don't directly affect Biophytis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biophytis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biophytis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biophytis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.